Thursday, 24 July 2008

Progress in Prostate Cancer Treatment

This weeks media reported promising results from a study in a small group of men with advanced prostate cancer who have few other treatment alternatives.

The study published in the Journal of Clinical Oncology is a phase I study, and provides early evidence of the safety and tolerability of abiraterone. The drug could be a potentially effective treatment for men with untreatable prostate cancer.
The full article is published early online and is:

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven.

Journal of Clinical Oncology 2008; Jul 21 [Epub ahead of print]

There is als a "Behind the Headlines" analysis on the new prostate cancer treatment also analysis on a new potential test for prostate cancer
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

About Us

The Kostoris Library offers a friendly and pleasant environment for studying.
Resources include:
> A large collection of online journals (which can be accessed from the library's web pages)
> A journal archive of specialist literature.
> A comprehensive specialist book collection and specialist cancer resources.
> A comprehensive range of services to help you keep up to date with the latest published research literature and health news.

Find out more on the library website

The views expressed on News@Kostoris Library website/weblog are from library staff and do not necessarily reflect the views of our employer. We uphold due respect to our institution, its employees, customers, partners, and competitors.